Literature DB >> 18326853

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.

Anna Ringborg1, Robby Nieuwlaat, Peter Lindgren, Bengt Jönsson, Dogan Fidan, Aldo P Maggioni, Jose Lopez-Sendon, Janina Stepinska, Dennis V Cokkinos, Harry J G M Crijns.   

Abstract

AIMS: To estimate costs of admission and costs incurred on an annual basis by patients with atrial fibrillation (AF) in Greece, Italy, Poland, Spain, and the Netherlands. METHODS AND
RESULTS: The Euro Heart Survey on AF enrolled 5333 patients with AF in 35 European countries in 2003 and 2004. This was a bottom-up cost study conducted for the five largest contributors in terms of patients enrolled. Quantities of resource use during the enrolment admission and during 1-year follow-up were inferred from survey data and multiplied by national unit costs in order to estimate per patient costs associated with AF for each country. Mean costs of inpatient admission of an AF patient were estimated at euro1363, euro5252, euro2322, euro6360, and euro6445 and mean costs incurred on an annual basis at euro1507, euro3225, euro1010, euro2315, and euro2328 in Greece, Italy, Poland, Spain, and the Netherlands, respectively. Inpatient care and interventional procedures were identified as the main drivers of costs, accounting for more than 70% of total annual costs in all five countries.
CONCLUSION: Estimates of the economic burden posed by AF are critical in light of the increasing importance of AF as a public health problem.

Entities:  

Mesh:

Year:  2008        PMID: 18326853     DOI: 10.1093/europace/eun048

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  47 in total

1.  Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Authors:  J L M Hendriks; R Nieuwlaat; H J M Vrijhoef; R de Wit; H J G M Crijns; R G Tieleman
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  Hospital costs associated with atrial fibrillation for patients with ischemic stroke aged 18-64 years in the United States.

Authors:  Guijing Wang; Heesoo Joo; Xin Tong; Mary G George
Journal:  Stroke       Date:  2015-04-07       Impact factor: 7.914

3.  The burden of atrial fibrillation in the Netherlands.

Authors:  H E Heemstra; R Nieuwlaat; M Meijboom; H J Crijns
Journal:  Neth Heart J       Date:  2011-09       Impact factor: 2.380

4.  Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Authors:  Kostas Athanasakis; Eleftheria Karampli; Dimitrios Tsounis; Aikaterini Bilitou; John Kyriopoulos
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 5.  Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Authors:  Annamaria Mascolo; Konrad Urbanek; Antonella De Angelis; Maurizio Sessa; Cristina Scavone; Liberato Berrino; Giuseppe Massimo Claudio Rosano; Annalisa Capuano; Francesco Rossi
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

6.  An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

Authors:  Etienne Aliot; Günter Breithardt; Josep Brugada; John Camm; Gregory Y H Lip; Panos E Vardas; Markus Wagner
Journal:  Europace       Date:  2010-05       Impact factor: 5.214

Review 7.  Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.

Authors:  Bernd Brüggenjürgen; Stefan Kohler; Nadja Ezzat; Thomas Reinhold; Stefan N Willich
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

Review 8.  Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation.

Authors:  Andrea Tampieri; Anna Maria Rusconi; Tiziano Lenzi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

9.  Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.

Authors:  Valeria Raparelli; Marco Proietti; Carmelo Buttà; Paolo Di Giosia; Domenico Sirico; Paolo Gobbi; Salvatore Corrao; Giovanni Davì; Anna Rita Vestri; Francesco Perticone; Gino Roberto Corazza; Francesco Violi; Stefania Basili
Journal:  Intern Emerg Med       Date:  2014-07-03       Impact factor: 3.397

10.  Atrial Fibrillation and Race - A Contemporary Review.

Authors:  Michael K D Amponsah; Emelia J Benjamin; Jared W Magnani
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.